Drug Database
Back to search

Belgium· BE-AMP-SAM661253-00

Sotyktu 6 mg

A deucravacitinib product containing deucravacitinib, registered in Belgium by Bristol-Myers Squibb Pharma. The same ATC class is registered in 12 of our 19 countries.

ATC L04AF07

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedSotyktu 6 mgATCL04AF07REGISTER NO.BE-AMP-SAM661253-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about deucravacitinibAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Deucravacitinib is registered in 12 of 19 countries.

Countries holding a registration under ATC L04AF07 (deucravacitinib), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search deucravacitinib products by name

Deucravacitinib · ATC L04AF07

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of deucravacitinib costs, country by country.

Normalised to the WHO defined daily dose (6 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Deucravacitinib · price per daily dose (6 mg)

USD · FX 28 Sept 2026

  • FR France$22.97
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Deucravacitinib
Manufacturer
Bristol-Myers Squibb Pharma
Country
Belgium (BE)
ATC code
L04AF07
ATC class
Deucravacitinib
Defined daily dose
6 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    4697421
    EUR 723.51
  • be_apb
    7738776

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Deucravacitinib in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All deucravacitinib products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Sotyktu
  • Liechtenstein · Sotyktu
  • Norway · Sotyktu

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b57982a8-b1c3-409a-aafc-59b675c9685a
GET /v1/drugs/b57982a8-b1c3-409a-aafc-59b675c9685a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Sotyktu 6 mg",
  "name_fr": "Sotyktu 6 mg",
  "name_nl": "Sotyktu 6 mg",
  "amp_code": "SAM661253-00",
  "strengths": [
    "6.0000",
    "44.0000"
  ],
  "pack_count": 8,
  "substances": [
    "Deucravacitinib",
    "Lactose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Deucravacitinib",
  "authorisation_numbers": [
    "EU/1/23/1718/001",
    "EU/1/23/1718/008",
    "EU/1/23/1718/002",
    "EU/1/23/1718/005",
    "EU/1/23/1718/006",
    "EU/1/23/1718/004",
    "EU/1/23/1718/003",
    "EU/1/23/1718/007"
  ]
}
API referenceMCP serverPlans

See everything about deucravacitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console